MetLife Investment Management’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,770
Closed -$197K 2926
2022
Q1
$197K Buy
1,770
+669
+61% +$83.6K ﹤0.01% 2361
2021
Q4
$182K Hold
1,101
﹤0.01% 2105
2021
Q3
$196K Hold
1,101
﹤0.01% 2115
2021
Q2
$208K Hold
1,101
﹤0.01% 2148
2021
Q1
$212K Hold
1,101
﹤0.01% 2026
2020
Q4
$237K Hold
1,101
﹤0.01% 1889
2020
Q3
$255K Hold
1,101
﹤0.01% 1711
2020
Q2
$361K Buy
1,101
+151
+16% +$31.8K ﹤0.01% 1555
2020
Q1
$143K Buy
+950
New +$85.8K ﹤0.01% 1876

Other funds holding VAPO

MetLife Investment Management's VAPO Position: Q2 2022 in Review

MetLife Investment Management sold out of Vapotherm, Inc. Common Stock (VAPO) in Q2 2022, closing a stake of 1,770 shares — an estimated $197K sold.

MetLife Investment Management first reported a position in VAPO in Q1 2020 and held it in 9 quarters. The position peaked at $361K in Q2 2020. 77 funds tracked by Wall St. Rank hold VAPO as of Q2 2022.

  • MetLife Investment Management reported no remaining Vapotherm, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • MetLife Investment Management sold 1,770 Vapotherm, Inc. Common Stock shares in Q2 2022, an estimated $197K.
  • MetLife Investment Management first reported a position in Vapotherm, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
  • MetLife Investment Management's Vapotherm, Inc. Common Stock position peaked at $361K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.